Literature DB >> 20118097

A survey of physician-led influenza immunization programs in schools.

Harry F Hull1.   

Abstract

To determine whether school-located immunization programs (SIPs) offer an efficient method of immunizing children aged 5 to 18 years now recommended for annual influenza immunization, the author interviewed 8 of 10 physicians (identified through media reports and personal communication) who independently conducted SIPs during 2005-2007. SIPs targeted 1 to 6 schools (mainly smaller private schools) and immunized <or=33% of eligible students. Permission and payment were obtained in advance. All SIPs offered live attenuated influenza vaccines. The physicians organized the SIPs and secured the commitment of school nurses and administrators. With 1 exception, physicians were able to recoup all costs associated with the SIP. All physicians found their experience personally rewarding and expressed a willingness to organize future SIPs. Physician-led SIPs are a viable means for immunizing schoolchildren against influenza and, if properly planned, can become self-sustaining annual events, particularly in private schools.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118097     DOI: 10.1177/0009922809346573

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

Review 1.  Current experience with school-located influenza vaccination programs in the United States: a review of the medical literature.

Authors:  Harry F Hull; Christopher S Ambrose
Journal:  Hum Vaccin       Date:  2011-02-01

2.  Factors associated with increased vaccination in 2009 H1N1 school-located influenza vaccination programs.

Authors:  Christopher S Ambrose; Frangiscos Sifakis
Journal:  Hum Vaccin       Date:  2011-08-01

3.  Costs of school-located influenza vaccination clinics in Maine during the 2009-2010 H1N1 pandemic.

Authors:  Bo-Hyun Cho; Garrett R Beeler Asay; Suchita A Lorick; Meredith L Tipton; Nancy L Dube; Mark L Messonnier
Journal:  J Sch Nurs       Date:  2012-08-22       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.